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Abstract
Background: Metastatic choroidal carcinomas that originated from the gastrointestinal tract are extremely rare. We
report a case of suspected solitary choroidal metastasis from gastric adenocarcinoma.
Case presentation: The patient was a 60-year-old man who had undergone laparoscopic distal gastrectomy with
D1+ lymphadenecetomy for gastric cancer. The clinical stage was T1bN0M0 (TNM classification), but the pathological
stage was T4aN0M0 beyond expectation. Adjuvant chemotherapy with oral Tegafur, Gimeracil, Oteracil potassium
(TS-1®) was initiated. But he suddenly complained of decreased visual acuity in his right eye about 8 months later. This
was suspected to be caused by choroidal metastasis of gastric adenocarcinoma. Chemotherapy with paclitaxel (PTX)
and intensity-modulated radiotherapy (IMRT) achieved complete remission and spared the patient from going blind.
Conclusions: This case demonstrates that we should be aware of the possibility of choroidal metastases, when visual
symptoms arise during treatment of gastric cancer.
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Background
Choroidal metastatic tumors from gastrointestinal tract
malignancies are extremely rare compared with more
common metastatic breast and pulmonary carcinomas.
The uvea consists of the iris, ciliary body, and choroid.
In a study of 420 patients with uveal metastasis, 196
came from primary cancers of the breast (47%), 90 from
the lung (21%), and 18 from the gastrointestinal tract
(4%). Moreover, metastasis was found in the iris in 90
(9%), ciliary body in 22 (2%), and choroid in 838 (88%)
of the 950 metastatic foci in the uvea [1]. Above all,
choroidal metastases from gastric adenocarcinoma have
been reported in only a few cases in the literature [2–4].
We report a rare case diagnosed as solitary right chor-
oidal metastasis from gastric adenocarcinoma that was
treated successfully.
Case presentation
A 60-year-old man was detected with an abnormality
in his medical checkup. Esophagogastroduodenoscopy
revealed an ulcerative lesion on the lesser curvature
of the stomach (Fig. 1a). Gastric biopsy specimens
from the ulcerative lesion showed signet ring cell car-
cinoma. We performed computed tomography (CT)
and fluorodeoxyglucose-positron emission tomography
(FDG-PET), but this did not reveal the primary lesion
or lymphnode metastasis (Fig. 1b). We made the clin-
ical diagnosis of T1bN0M0 gastric cancer in TNM
classification and performed a laparoscopic distal
gastrectomy with D1+ lymphadenectomy (Fig. 1c, d).
Pathological findings showed exposure of the tumor
at the serosal surface at only a single site in the
specimen (Fig. 2a, b). We could not recognize the
tumor penetration of the serosa intraoperatively. The
finding of (tumor exposes on the surface of serosa)
T4a was first detected microscopically. The final
pathological diagnosis was MU, less, post, type 0-IIc+III
(advanced), 30 × 23 mm, por2>sig, pT4a, sci, INFc,
ly1, v1, pN0 (0/40), PM0 (8 mm), and DM0 (90 mm,
HER2 score 0). We performed preoperative endoscopic
marking by clips to 2-cm endoscopic margin and
confirmed that the clips were existed in the resected
specimen. But, the proximal resected margin was 8 mm in
pathological findings, because the submucosal invasion
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was more widespread than the macroscopic margin. Thus,
the pathological stage was T4aN0M0 beyond expectation.
He began a year of adjuvant chemotherapy with Tegafur,
Gimeracil, Oteracil potassium (TS-1®) 80 mg/body. How-
ever, he suddenly complained of visual disturbance in his
right eye about 8 months later (Fig. 3: Clinical course).
To evaluate the cause of the visual disturbance, fundo-
scopic examination and complete ophthalmologic exami-
nations were performed (Fig. 4). Fundoscopic examination
revealed profuse exudate, subretinal hemorrhage, and
retinal detachment suggesting metastatic choroidal tumor.
Ultrasonography showed retinal detachment by choroidal
tumor, and optical coherence tomographic examination
showed macular edema and irregular elevation of chor-
oidal tissue. Magnetic resonance imaging (MRI) was also
performed and a smooth and sharply marginated tumor
was detected in his right ocular fundus in T1- and T2-
weighted images (Fig. 5). We could not detect any other
origins for metastatic tumor of the choroid, although we
performed CT, endoscopy, and FDG-PET.
We started the second line chemotherapy with weekly
intravenous paclitaxel (100 mg/body) and intensity-
modulated radiotherapy (IMRT) (40 Gy) to the right
orbit. Although his retinal detachment was gradually
worsened, sub-Tenon injection with dexamethasone was
performed. Consequently, the retinal detachment was
gradually improved and he was spared from going blind.
There was a gradual decrease in carcinoembryonic
antigen (CEA) from 7.9 ng/ml at diagnosis to 5.1 ng/ml
after the chemoradiation therapy. He was continued to be
treated with paclitaxel (PTX), 14 courses in total. At this
point, we identified a complete response on PET and
fundoscopic examination, and then we changed his
chemotherapy to capecitabine (1200 mg/body) alone. His
recurrence-free survival period is 3 years until now
(Fig. 3).
Discussion
It is considered that a number of reports about meta-
static choroidal tumor have been increasing with the
increase of cancer patients and improvement of survival
rates with the advance of treatment. There are few reports
about the cases from gastric adenocarcinoma [2–4].
Moreover, these reports just only show the choroidal me-
tastases as one of the sites of systemic metastases, and
there is no report about a solitary choroidal metastasis
pointed out during adjuvant chemotherapy and achieved
good local control.
Choroidal metastasis is considered to occur by
hematogenous spread. This seems to be common in
cases of lung cancer and breast cancer. In the English
language literature, we could not find any previous articles
about the risk or morbidity rate limited to only gastric
cancer owing to its rarity. In our case, the microscopic
vascular invasion of poorly differentiated adenocarcinoma
or signet ring cell carcinoma was thought to be involved
Fig. 1 Preoperative examinations and intraoperative findings. a Esophagogastroduodenoscopy revealed an IIc+III lesion and a signet ring cell
carcinoma on biopsy. b FDG-PET/CT could not detect other lymphnode or organ metastases and could not detect the exposure of the tumor
at the serosal surface of the stomach. c The lesion was identified as an ulcer scar during laparoscopic distal gastrectomy. St: Stomach, Eso: esophagus.
d Schema of Fig. 1C. USAD: ultrasonic-activated device
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in the choroidal metastasis. Also, in approximately
half of these patients, their primary sites are un-
detected despite the systematic evaluation, and they
die of diffuse metastatic disease and their primary
sites remain unknown [1].
In the diagnosis, it is important to differentiate between
malignant melanoma and metastatic tumor, because
melanoma and metastatic tumors are the two most
common malignant choroidal tumors [5]. Malignant
melanoma is seen as a localized lesion on fundoscopic
examination in general; therefore, our findings were
compatible with metastatic adenocarcinoma. In the
literature, it has been reported that N-isopropyl-p-
(123I) iodoamphetamine single-photon emission com-
puted tomography (123I-IMP SPECT) and MRI are useful
in distinguishing the two [6, 7]. We were appreciative of
the accuracy of MRI, and the T1-weighted image was
isointense and the T2-weighted image was hypointense, so
their findings were compatible with metastatic tumor, and
not melanoma. Although we could not provide a definitive
diagnosis to our case because of the difficulty of choroidal
biopsy, we diagnosed metastasis of gastric adenocarcin-
oma with the findings from various imaging studies.
Because some authors have reported the diagnosis by
fundoscopic findings alone in previous literatures [2, 4],
we assume that direct biopsy may not be necessary for
diagnosing clinically.
Chemotherapy and external beam radiotherapy may be
effective. In our case, chemoradiation therapy (CRT)
achieved complete remission and saved the patient from
going blind as well. It is reported that choroidal metasta-
sis from gastric adenocarcinoma is almost resistant to
various therapies and is presented with multiple organ
Fig. 3 Clinical course. (M: months; Op: operation; TS-1: Tegafur, Gimeracil, Oteracil potassium; PTX: paclitaxel; IMRT: intensity-modulated radiotherapy;
CEA: carcinoembryonic antigen)
Fig. 2 Pathological findings. a Resected specimen shows a cancer
measuring 30 × 22 mm in the form of superficial depressed and
excavated type. b Histopathological findings show poorly differentiated
adenocarcinoma being exposed at the serosal surface only in the slice
#5 only (hematoxylin and eosin stain, ×40)
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metastasis and severe prognosis [1, 3]. It is interesting
that multimodal therapy was effective in our case and
local control for the metastatic ocular lesion was
achieved. Although the issue here is how we can explain
the success in the treatment in this case, it is reasonable
to assume that the metastatic choroidal lesion was
fortunately localized within a small range and the symp-
tom was detected in an early stage. The reason why
we chose PTX is that we considered PTX as the sec-
ond line. We thought standard TS-1 and cisplatin
regimen will not be effective, because the choroidal
metastasis was occurred during the adjuvant therapy
with TS-1. Furthermore, we could not treat aggres-
sively with a platinum-based combination regimen be-
cause of his chronic pancytopenia. On the other hand,
we estimated that there is the risk of recurrence or
other metastasis in several years, even once he had a
complete remission. Although we debated whether or
not to resume to treat with TS-1, TS-1 was predicted
to have no effect in the first adjuvant chemotherapy.
So, another oral anticancer drug that is approved for
the management of gastric cancer was considered to
be the best choice. Although there were few clinical
trials for the efficacy of capecitabine for gastric cancer
alone [8, 9], we considered capecitabine feasible for
maintenance therapy after CRT. Currently, we intend
to continue some kind of systematic chemotherapy
for some time in the future with careful observation.
Conclusions
We reported a rare case of gastric adenocarcinoma who
presented with unilateral solitary choroidal metastasis
during adjuvant chemotherapy. Therefore, it is important
to be aware of the possibility of a metastatic choroidal
tumor, when visual disturbances do arise during gastric
cancer treatment.
Fig. 4 Ophthalmologic examinations. a Fundoscopic examination. b Ultrasonography. c Optical coherence tomographic examination
Fig. 5 Magnetic resonance imaging (MRI). An elevated choroidal
tumor was detected. The T1-weighted image was isointense, and
the T2-weighted image was hypointense
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